- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-2013
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
SGLT2 and cancer ; volume:472 ; number:9 ; day:20 ; month:8 ; year:2020 ; pages:1407-1414 ; date:9.2020
Pflügers Archiv ; 472, Heft 9 (20.8.2020), 1407-1414, 9.2020
- Urheber
-
Wright, Ernest M.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00424-020-02448-4
- URN
-
urn:nbn:de:101:1-2020102121570214655118
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:36 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Wright, Ernest M.
- SpringerLink (Online service)
Ähnliche Objekte (12)
SGLT2 inhibitor promotes mitochondrial dysfunction and ER-phagy in colorectal cancer cells
The SGLT2 inhibitor canagliflozin suppresses growth and enhances prostate cancer response to radiotherapy
Targeting high glucose-induced epigenetic modifications at cardiac level: the role of SGLT2 and SGLT2 inhibitors
SGLT2-inhibitors; more than just glycosuria and diuresis
SGLT2-Hemmer : Geringere Mortalität und Nierenschutz
Direct cardiac effects of SGLT2 inhibitors
A Fluorescent Glucose Transport Assay for Screening SGLT2 Inhibitors in Endogenous SGLT2-Expressing HK-2 Cells
SGLT2 inhibitors and the cardiac rhythm: unraveling the connections
SGLT2 inhibition eliminates senescent cells and alleviates pathological aging
The relationship between SGLT2 and systemic blood pressure regulation
SGLT2 inhibition and adipose tissue metabolism: current outlook and perspectives
SGLT2-Inhibitoren – Effektive Blutzuckerregulation über die Niere
SGLT2 inhibitor promotes mitochondrial dysfunction and ER-phagy in colorectal cancer cells
The SGLT2 inhibitor canagliflozin suppresses growth and enhances prostate cancer response to radiotherapy
Targeting high glucose-induced epigenetic modifications at cardiac level: the role of SGLT2 and SGLT2 inhibitors
SGLT2-inhibitors; more than just glycosuria and diuresis
SGLT2-Hemmer : Geringere Mortalität und Nierenschutz
Direct cardiac effects of SGLT2 inhibitors
A Fluorescent Glucose Transport Assay for Screening SGLT2 Inhibitors in Endogenous SGLT2-Expressing HK-2 Cells
SGLT2 inhibitors and the cardiac rhythm: unraveling the connections
SGLT2 inhibition eliminates senescent cells and alleviates pathological aging
The relationship between SGLT2 and systemic blood pressure regulation
SGLT2 inhibition and adipose tissue metabolism: current outlook and perspectives
SGLT2-Inhibitoren – Effektive Blutzuckerregulation über die Niere
SGLT2 inhibitor promotes mitochondrial dysfunction and ER-phagy in colorectal cancer cells
The SGLT2 inhibitor canagliflozin suppresses growth and enhances prostate cancer response to radiotherapy
Targeting high glucose-induced epigenetic modifications at cardiac level: the role of SGLT2 and SGLT2 inhibitors
SGLT2-inhibitors; more than just glycosuria and diuresis
SGLT2-Hemmer : Geringere Mortalität und Nierenschutz
Direct cardiac effects of SGLT2 inhibitors
A Fluorescent Glucose Transport Assay for Screening SGLT2 Inhibitors in Endogenous SGLT2-Expressing HK-2 Cells
SGLT2 inhibitors and the cardiac rhythm: unraveling the connections
SGLT2 inhibition eliminates senescent cells and alleviates pathological aging
The relationship between SGLT2 and systemic blood pressure regulation
SGLT2 inhibition and adipose tissue metabolism: current outlook and perspectives